325 related articles for article (PubMed ID: 29020905)
1. The incidence and multiplicity rates of keratinocyte cancers in Australia.
Pandeya N; Olsen CM; Whiteman DC
Med J Aust; 2017 Oct; 207(8):339-343. PubMed ID: 29020905
[TBL] [Abstract][Full Text] [Related]
2. Age group-specific changes in keratinocyte cancer treatment rates in Australia, 2012-2021: a retrospective cohort study based on MBS claims data.
Olsen CM; Pandeya N; Neale RE; Whiteman DC
Med J Aust; 2024 May; 220(9):472-479. PubMed ID: 38685827
[TBL] [Abstract][Full Text] [Related]
3. Keratinocyte cancers in South Australia: incidence, geographical variability and service trends.
Adelson P; Sharplin GR; Roder DM; Eckert M
Aust N Z J Public Health; 2018 Aug; 42(4):329-333. PubMed ID: 29972285
[TBL] [Abstract][Full Text] [Related]
4. Incidence Estimate of Nonmelanoma Skin Cancer (Keratinocyte Carcinomas) in the U.S. Population, 2012.
Rogers HW; Weinstock MA; Feldman SR; Coldiron BM
JAMA Dermatol; 2015 Oct; 151(10):1081-6. PubMed ID: 25928283
[TBL] [Abstract][Full Text] [Related]
5. Medicare claims data reliably identify treatments for basal cell carcinoma and squamous cell carcinoma: a prospective cohort study.
Thompson BS; Olsen CM; Subramaniam P; Neale RE; Whiteman DC
Aust N Z J Public Health; 2016 Apr; 40(2):154-8. PubMed ID: 26558736
[TBL] [Abstract][Full Text] [Related]
6. Skin cancer in Geraldton, Western Australia: a survey of incidence and prevalence.
Kricker A; English DR; Randell PL; Heenan PJ; Clay CD; Delaney TA; Armstrong BK
Med J Aust; 1990 Apr; 152(8):399-407. PubMed ID: 2329947
[TBL] [Abstract][Full Text] [Related]
7. Exclusive development of a single type of keratinocyte skin cancer: evidence from an Australian population-based cohort study.
Keim U; van der Pols JC; Williams GM; Green AC
J Invest Dermatol; 2015 Mar; 135(3):728-733. PubMed ID: 25233075
[TBL] [Abstract][Full Text] [Related]
8. Keratinocyte cancer incidence in Australia: a review of population-based incidence trends and estimates of lifetime risk.
Olsen CM; Pandeya N; Green AC; Ragaini BS; Venn AJ; Whiteman DC
Public Health Res Pract; 2022 Mar; 32(1):. PubMed ID: 35290995
[TBL] [Abstract][Full Text] [Related]
9. Forearm hair density and risk of keratinocyte cancers in Australian adults.
von Schuckmann LA; Hughes MC; Green AC; van der Pols JC
Arch Dermatol Res; 2016 Nov; 308(9):617-624. PubMed ID: 27590883
[TBL] [Abstract][Full Text] [Related]
10. Assessment of Incidence Rate and Risk Factors for Keratoacanthoma Among Residents of Queensland, Australia.
Claeson M; Pandeya N; Dusingize JC; Thompson BS; Green AC; Neale RE; Olsen CM; Whiteman DC
JAMA Dermatol; 2020 Dec; 156(12):1324-1332. PubMed ID: 33026421
[TBL] [Abstract][Full Text] [Related]
11. Keratinocyte cancer excisions in Australia: Who performs them and associated costs.
Thompson BS; Pandeya N; Olsen CM; Dusingize JC; Green AC; Neale RE; Whiteman DC
Australas J Dermatol; 2019 Nov; 60(4):294-300. PubMed ID: 31012087
[TBL] [Abstract][Full Text] [Related]
12. The burden of non-melanoma skin cancers in Auckland, New Zealand.
Pondicherry A; Martin R; Meredith I; Rolfe J; Emanuel P; Elwood M
Australas J Dermatol; 2018 Aug; 59(3):210-213. PubMed ID: 29350397
[TBL] [Abstract][Full Text] [Related]
13. Association of ACE inhibitors and angiotensin receptor blockers with keratinocyte cancer prevention in the randomized VATTC trial.
Christian JB; Lapane KL; Hume AL; Eaton CB; Weinstock MA;
J Natl Cancer Inst; 2008 Sep; 100(17):1223-32. PubMed ID: 18728281
[TBL] [Abstract][Full Text] [Related]
14. Body-site distribution of skin cancer, pre-malignant and common benign pigmented lesions excised in general practice.
Youl PH; Janda M; Aitken JF; Del Mar CB; Whiteman DC; Baade PD
Br J Dermatol; 2011 Jul; 165(1):35-43. PubMed ID: 21443534
[TBL] [Abstract][Full Text] [Related]
15. Cigarette Smoking and the Risks of Basal Cell Carcinoma and Squamous Cell Carcinoma.
Dusingize JC; Olsen CM; Pandeya NP; Subramaniam P; Thompson BS; Neale RE; Green AC; Whiteman DC;
J Invest Dermatol; 2017 Aug; 137(8):1700-1708. PubMed ID: 28414022
[TBL] [Abstract][Full Text] [Related]
16. Aspirin and nonsteroidal anti-inflammatory drug use and keratinocyte cancers: a large population-based cohort study of skin cancer in Australia.
Pandeya N; Olsen CM; Thompson BS; Dusingize JC; Neale RE; Green AC; Whiteman DC;
Br J Dermatol; 2019 Oct; 181(4):749-760. PubMed ID: 30920641
[TBL] [Abstract][Full Text] [Related]
17. Non-melanoma skin cancer in Australia: the 2002 national survey and trends since 1985.
Staples MP; Elwood M; Burton RC; Williams JL; Marks R; Giles GG
Med J Aust; 2006 Jan; 184(1):6-10. PubMed ID: 16398622
[TBL] [Abstract][Full Text] [Related]
18. Risk of subsequent cutaneous malignancy in patients with prior keratinocyte carcinoma: a systematic review and meta-analysis.
Flohil SC; van der Leest RJ; Arends LR; de Vries E; Nijsten T
Eur J Cancer; 2013 Jul; 49(10):2365-75. PubMed ID: 23608733
[TBL] [Abstract][Full Text] [Related]
19. A Model to Predict the Risk of Keratinocyte Carcinomas.
Whiteman DC; Thompson BS; Thrift AP; Hughes MC; Muranushi C; Neale RE; Green AC; Olsen CM;
J Invest Dermatol; 2016 Jun; 136(6):1247-1254. PubMed ID: 26908057
[TBL] [Abstract][Full Text] [Related]
20. Association of Age, Sex, Race, and Geographic Region With Variation of the Ratio of Basal Cell to Cutaneous Squamous Cell Carcinomas in the United States.
Lukowiak TM; Aizman L; Perz A; Miller CJ; Sobanko JF; Shin TM; Giordano CN; Higgins HW; Etzkorn JR
JAMA Dermatol; 2020 Nov; 156(11):1192-1198. PubMed ID: 32845319
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
